Gamco Investors INC. ET AL Has $8.95 Million Position in CVS Health Corporation $CVS

Gamco Investors INC. ET AL lowered its stake in shares of CVS Health Corporation (NYSE:CVS) by 11.6% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 112,713 shares of the pharmacy operator’s stock after selling 14,768 shares during the quarter. Gamco Investors INC. ET AL’s holdings in CVS Health were worth $8,945,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Chase Investment Counsel Corp lifted its stake in CVS Health by 8.7% during the fourth quarter. Chase Investment Counsel Corp now owns 4,566 shares of the pharmacy operator’s stock worth $362,000 after purchasing an additional 364 shares during the last quarter. North Dakota State Investment Board bought a new stake in CVS Health during the fourth quarter worth $3,479,000. Elyxium Wealth LLC bought a new stake in CVS Health during the fourth quarter worth $86,000. Rossmore Private Capital lifted its stake in CVS Health by 20.4% during the fourth quarter. Rossmore Private Capital now owns 23,474 shares of the pharmacy operator’s stock worth $1,863,000 after purchasing an additional 3,980 shares during the last quarter. Finally, Leuthold Group LLC lifted its stake in CVS Health by 0.3% during the fourth quarter. Leuthold Group LLC now owns 42,758 shares of the pharmacy operator’s stock worth $3,393,000 after purchasing an additional 141 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

CVS Health Stock Down 1.9%

Shares of NYSE:CVS opened at $94.18 on Wednesday. The firm has a market cap of $120.16 billion, a P/E ratio of 41.49, a P/E/G ratio of 0.94 and a beta of 0.60. The company has a quick ratio of 0.66, a current ratio of 0.87 and a debt-to-equity ratio of 0.78. CVS Health Corporation has a 12-month low of $58.50 and a 12-month high of $98.43. The business has a fifty day simple moving average of $79.39 and a 200 day simple moving average of $78.76.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, May 6th. The pharmacy operator reported $2.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.21 by $0.36. The business had revenue of $100.43 billion during the quarter, compared to analyst estimates of $94.99 billion. CVS Health had a return on equity of 11.88% and a net margin of 0.72%.CVS Health’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same period last year, the company earned $2.25 EPS. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. Analysts predict that CVS Health Corporation will post 7.44 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, May 4th. Investors of record on Thursday, April 23rd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 2.8%. The ex-dividend date of this dividend was Thursday, April 23rd. CVS Health’s dividend payout ratio (DPR) is currently 117.18%.

Key CVS Health News

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS Health and WGU launched an online pre-pharmacy degree program aimed at building a pipeline of future pharmacists nationwide, which could help address labor shortages and support CVS’s retail pharmacy operations. CVS Health(R) and WGU Launch Online Pre-Pharmacy Degree Program for Future Pharmacists Nationwide
• Positive Sentiment: CVS also backed EnsembleIQ’s campaign supporting retail pharmacy as a way to help fill healthcare gaps, reinforcing CVS’s role in community pharmacy and care access. EnsembleIQ’s DSN, a Trusted Source in the Community Pharmacy Space, Launches Campaign in Support of Retail Pharmacy Filling Health Care Gaps
• Positive Sentiment: CVS Health published a study showing many Medicare members struggle with digital health literacy, which supports the company’s push to invest in digital tools and member engagement. CVS Health study reveals a need for greater digital health literacy for Medicare members

Insider Transactions at CVS Health

In related news, EVP Tilak Mandadi sold 69,551 shares of the firm’s stock in a transaction on Friday, May 8th. The stock was sold at an average price of $89.58, for a total transaction of $6,230,378.58. Following the completion of the transaction, the executive vice president directly owned 10,133 shares of the company’s stock, valued at $907,714.14. This trade represents a 87.28% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.85% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

CVS has been the subject of several recent analyst reports. TD Cowen upped their target price on CVS Health from $105.00 to $110.00 and gave the stock a “buy” rating in a research note on Monday, May 11th. Leerink Partners restated an “outperform” rating and set a $98.00 target price on shares of CVS Health in a research note on Thursday, March 5th. Morgan Stanley upped their target price on CVS Health from $93.00 to $106.00 and gave the stock an “overweight” rating in a research note on Thursday, May 14th. The Goldman Sachs Group upped their target price on CVS Health from $95.00 to $97.00 and gave the stock a “buy” rating in a research note on Thursday, February 12th. Finally, Deutsche Bank Aktiengesellschaft increased their price target on CVS Health from $88.00 to $92.00 and gave the company a “buy” rating in a research note on Thursday, May 7th. Twenty-two investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat, CVS Health presently has an average rating of “Moderate Buy” and a consensus price target of $98.08.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.